1-15438406-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The variant allele was found at a frequency of 0.00215 in 1,604,676 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0021 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 5 hom. )
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0920
Genes affected
CTRC (HGNC:2523): (chymotrypsin C) This gene encodes a member of the peptidase S1 family. The encoded protein is a serum calcium-decreasing factor that has chymotrypsin-like protease activity. Alternatively spliced transcript variants have been observed, but their full-length nature has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-15438406-C-T is Benign according to our data. Variant chr1-15438406-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 240761.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=3, Benign=1}.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
use as main transcript | n.15438406C>T | intergenic_region | ||||||
CTRC | NM_007272.3 | c.-59C>T | upstream_gene_variant | ENST00000375949.5 | NP_009203.2 | |||
CTRC | XM_011540550.2 | c.-59C>T | upstream_gene_variant | XP_011538852.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTRC | ENST00000375949.5 | c.-59C>T | upstream_gene_variant | 1 | NM_007272.3 | ENSP00000365116.4 | ||||
CTRC | ENST00000375943.6 | c.-59C>T | upstream_gene_variant | 1 | ENSP00000365110.2 | |||||
CTRC | ENST00000476813.5 | n.-47C>T | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00215 AC: 327AN: 152196Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
327
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00216 AC: 3130AN: 1452362Hom.: 5 Cov.: 30 AF XY: 0.00211 AC XY: 1524AN XY: 723316
GnomAD4 exome
AF:
AC:
3130
AN:
1452362
Hom.:
Cov.:
30
AF XY:
AC XY:
1524
AN XY:
723316
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00215 AC: 327AN: 152314Hom.: 2 Cov.: 32 AF XY: 0.00222 AC XY: 165AN XY: 74482
GnomAD4 genome
AF:
AC:
327
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
165
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hereditary pancreatitis Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 23, 2023 | The CTRC c.-59C>T variant (rs183658182) has been reported in pancreatitis patients (Ballard 2015, Masson 2008), but not at a significantly higher frequency compared to unaffected individuals. This variant is found in the non-Finnish European population with an allele frequency of 0.337% (52/15,428 alleles) in the Genome Aggregation Database. This variant occurs in the 5' untranslated region at a nucleotide that is weakly conserved and does not create a novel protein translation start codon. Due to limited information, the clinical significance of this variant is uncertain at this time. References: Ballard DD et al. Evaluating Adults With Idiopathic Pancreatitis for Genetic Predisposition: Higher Prevalence of Abnormal Results With Use of Complete Gene Sequencing. Pancreas. 2015 Jan;44(1):116-21. PMID: 25251442. Masson E et al. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 2008 Feb;123(1):83-91. PMID: 18172691. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 24, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 06, 2021 | - - |
CTRC-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2024 | The CTRC c.-59C>T variant is located in the 5' untranslated region. This variant was reported in four individuals with idiopathic chronic pancreatitis, one individual with familial chronic pancreatitis, and one individual with hereditary pancreatitis but was also found in two controls (Table 4, Masson et al. 2008. PubMed ID: 18172691). This variant was also reported in two individuals with unexplained pancreatitis, although one individual also carried a CFTR variant (Supplementary Table, Ballard et al. 2015. PubMed ID: 25251442). This variant is reported in 0.34% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one homozygous individual, and has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from benign to uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/240761/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at